by N Ashcherkin 2024The medication lists of the diabetic patients with septic shock were reviewed to identify those prescribed SGLT2i. The SGLT2i group included
Recommendation for addition of an SGLT2i (or GLP-1RA where SGLT2i is not tolerated or contraindicated) to other glucose lowering medication(s) in adults
Recommendation for addition of an SGLT2i (or GLP-1RA where SGLT2i is not tolerated or contraindicated) to other glucose lowering medication(s) in adults
Antihyperglycemic medication use was assessed on the drug class level including metformin, sulfonylureas, thiazolidinediones, SGLT2i
Recommendation for addition of an SGLT2i (or GLP-1RA where SGLT2i is not tolerated or contraindicated) to other glucose lowering medication(s) in adults
Among people with Type 2 diabetes recommended for first-line SGLT2i treatment, only 11.9% received a prescription for an SGLT2i, and there was no significant difference in prescription between people who met the criteria for first-line SGLT2i treatment versus people who did not meet the criteria for first-line SGLT2i treatment.
o SGLT2i's: empagliflozin and dapagliflozin (canagliflozin and ertugliflozin The following chart is a list of oral and injectable diabetes medications
by A Paul 2024 Cited by 2Sodium-glucose co-transporter-2 inhibitors (SGLT2is), commonly referred to as the flozin group of drugs List J. Dapagliflozin a
Recommendation for addition of an SGLT2i (or GLP-1RA where SGLT2i is not tolerated or contraindicated) to other glucose lowering medication(s) in adults
Comments